🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

💐The BOUQUET trial is a novel biomarker-directed platform trial in rare #OvarianCancer - so brilliant and allows seamless enrollment of #RareCancers #ESMO2023 #gyncsm

@seppobauer Breelyn Wilky, MD 🎗 Ray-Coquard Isabelle Silvia Stacchiotti Robin Lewis Jones Viktor Grünwald I echo @seppobauer! very solid results of LMS-04, kudos to the investigators: 1st PFS and OS benefit in advanced #leiomyosarcoma is a milestone! We always wish to know more to put trial results into context and decipher the experimental arm:doxo-trabe+\-surgery+\-maintenance

Francois Gouin: sarcoma surgeon in CLB Unicancer and FSG- starts today his global solo race around the world without assistance! HORN, GOOD HOPE, and LEUWIN beware! SOOO PROUD!!!!

Don’t miss today’s #ESMOVirtualPlenary session to stay up to date with the latest, original data in #cervicalcancer. ⏰ Today(3 Nov) at 18:30 CET. Full programme: ow.ly/SxFK50Q3Vzj GEICO-Spanish Gynaecological Cancer Research Group Ray-Coquard Isabelle #GYNSM

❗ SAVE THE DATE !! Réunion régionale FEM-NET Lieu : Novotel Lyon Bron Eurexpo Horaires : 18h-21h Et aussi à 13h30 la plénière Sein/Gynécologie d'ONCO AURA Inscription gratuite et obligatoire. Places limitées 👉forms.office.com/e/5nbWCs5Zfw

📣 Jean-Yves Blay, Scientific Co-Chair, invites you to register for #ESMOSarcomaAndRareCancers24 (14-16 Mar). Whatever your #RareCancer specialisation, you will be sure to find topics of interest to you at this important event. Register now 👉 ow.ly/vtzB50QfqcN #sarcoma

▶️ Live : Cours St Paul de Vence - Cannes 2024 La session GINECO a démarré !  Au programme de l'après-midi : les nouveautés dans le cancer du col et de l'endomètre ainsi qu'un point sur les traitements et avancées dans les #cancers de la vulve et de l'ovaire.

En cette #journéemondialecontrelecancer découvrez l’émission captivante Têtes Chercheuses en replay. Plongez dans l’univers des chercheurs dévoués à l origine des percées scientifiques qui façonnent l’avenir de la lutte contre le cancer. youtube.com/watch?v=B2N913… #WorldCancerDay

Teratoma in the primary tumor or in post-chemotherapy residual non-retroperitoneal disease is not associated with inferior survival in metastatic non-seminomatous germ cell tumors. ja.ma/3u4Xn83

Starting at 18h CET today ‼️ The #GynOnc sessions of the OncoAlert Colloquium! Don’t miss OncoAlert 's free, multidisciplinary event. 🙌 The ESGO speakers on #gynonc are: 🔸Nicole Concin 🇦🇹 🔸Isabelle Ray-Coquard Ray-Coquard Isabelle 🇫🇷 🔸Viola Heinzelmann-Schwartz 🇨🇭 🔸Nicolo

The new uterine sarcoma guidelines are ready to present at #ESGO2024 in Barcelona! The guidelines working group, which is a collaboration between ESGO, EURACAN and GCIG, held its last meeting in Milan 🇮🇹 this week at L'Istituto Nazionale dei Tumori to finalize the

Latest ESMO Open podcast 📢 First-line maintenance treatment of high grade serous #OvarianCancer with a BRCA1/2 mutation, with Margherita Turinetto, Ray-Coquard Isabelle & Charlie Gourley. ow.ly/gvQ250QH3Ny #GynCSM

[LES SEANCES DE L'ANM] 🔴Suivez en direct la séance de demain à 14h30 « Avancées dans le #cancer de l’#Ovaire : vers une #guérison ? » Institut de Cancérologie de l'Ouest Centre Jean PERRIN Centre Leon Berard ➡️bit.ly/475rTgb

Apply now for the #ESMOPreceptorship on #UterineCancer: multidisciplinary management, standards of care, therapeutic targets and future perspectives. 🌏 Lugano (CH), 11-12 July 2024. 📍 Deadline to apply: 06 May 2024. ow.ly/9PnH50Ruofw Ilaria Colombo Ray-Coquard Isabelle #GynCSM

Congrats Jean-Yves Blay & colleagues of #FrenchSarcomaGroup for completing study of #6vs3years of #adjuvant #imatinib 💊i n pts w/ #highrisk #GISTs. Presented at ESMO - Eur. Oncology AACR #virtualplenary over last #2days with #specific discussions from #APAC #discussants as well!

ROCSAN Part I Study Misses 16-Week ORR End Point in Endometrial or Ovarian Carcinosarcoma Ray-Coquard Isabelle ESMO - Eur. Oncology #ESMOGynae24 #gyncsm onclive.com/view/rocsan-pa…

📢 📰 The GINECO randomized phase II study #Neopembrov has just been #published together with the #translational #research in NATURE COMMUNICATION.

New guidelines for uterine sarcomas!!!🎉 IJGC IJGC Fellows ESGO European Network of Young Gynae Oncologists Biruni Üniversitesi Biruni Kütüphane

Two papers. On the left, a non-randomized, non-crossover study showing that a one-off sauna exposure significantly decreased arterial stiffness, with implications on cardiovascular health. On the right, a randomized, crossover (more robust) study, showing no benefits on

🌍 11 février - Journée mondiale des malades 🔬 Depuis 30 ans, ARCAGY-GINECO est un acteur clé de la #recherche clinique et translationnelle en onco-gynéco. Nous améliorons la prise en charge des patientes en coordonnant des essais cliniques en France et à l’international. À